© 2023 BioMarin. All rights reserved.

BioMarin to Participate in Four Upcoming Virtual Investor Conferences
- J.P. Morgan U.S. All Stars Conference on September 16 at 11:00am ET/4:00BST
- Cantor Virtual Global Healthcare Conference on September 16 at 2:40pm ET
- BofA Global Healthcare Conference 2020 on September 17 at 11:45am ET/4:45pm BST
- Morgan Stanley 18th Annual Global Healthcare Conference on September 17 at 2:00pm ET
Sep 15, 2020

SAN RAFAEL, Calif., Sept. 15, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. 

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.




Traci McCarty                                             

Debra Charlesworth

BioMarin Pharmaceutical Inc.                         

BioMarin Pharmaceutical Inc.

(415) 455-7558                                                

(415) 455-7451


SOURCE BioMarin Pharmaceutical Inc.